Methadone for cancer pain

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Nicholson, Alexander B ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Analgesics, opioid *therapeutic use ; Humans; Methadone *therapeutic use ; Morphine therapeutic use ; Neoplasms *complications ; Pain measurement; Pain *drug therapy; etiology ; Randomized controlled trials as topic

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; COCAINE; DEXTROMORAMIDE; DIAMORPHINE; IBUPROFEN; METHADONE; MORPHINE; PETHIDINE; PLACEBO;

ANALGESIA; CANCER PAIN; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DETERIORATION; DIPLOPIA; DISEASE SEVERITY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; HYPOTENSION; INJECTION SITE PAIN; NAUSEA AND VOMITING; NEUROPATHIC PAIN; PAIN ASSESSMENT; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; SWEATING; TREATMENT RESPONSE; XEROSTOMIA;

EID: 44949110102     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003971.pub3     Document Type: Review

References (62)

1. Beaver 1967 {published data only} Beaver WT, Wallenstein SL, Houde RW, Rogers A. A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone. Clinical Pharmacololgy and Therapeutics 1967;8(3):415-26.
2. Bruera 2004 {published data only} Bruera E, Palmer JL, Bosnjak S, Rico MA, Moyano J, Sweeney C, et al.Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. Journal of Clinical Oncology 2004;22(1):185-92.
3. Ferrer-Brechner 1984 {published data only} Ferrer-Brechner T, Ganz P. Combination therapy with ibuprofen and methadone for chronic cancer pain. American Journal of Medicine 1984;77(1A):78-83.
4. Gourlay 1986 {published data only} Gourlay GK, Cherry DA, Cousins MJ. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain 1986;25:297-312.
5. Grochow 1989 {published data only} Grochow L, Sheidler V, Grossman S, Green L, Enterline J. Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomised, double blind study. Pain 1989;38:151-7.
6. Matts 1964 {published data only} Matts SGF, Swan CHF, Wharton BA. Double blind trial of dextromoramide, methadone and pethidine in the treatment of severe pain. Postgraduate Medical Journal 1964;40:103-5.
7. Mercadante 1998 {published data only} Mercadante S, Casuccio A, Agnello A, Serretta R, Calderone L, Barresi L. Morphine versusmethadone in the pain treatment of advanced cancer patients followed up at home. Journal of Clinical Oncology 1998;16(11):3656-61.
8. Twycross 1977 {published data only} Twycross RG. A comparison of diamorphine-with-cocaine and methadone (letter). British Journal of Clinical Pharmacology 1977;61(4):691-3.
9. Ventafridda 1986 {published data only} Ventafridda V, Ripamonti C, Bianchi M, Sbanotto A, De Conno F. A randmised study on oral morphine and methadone in the treatment of cancer pain. Journal of Pain and Symptom Management 1986;1:203-7.
10. Altier 2005 Altier N, Dion D, Boulanger A, Choiniere M. Management of chronic neuropathic pain with methadone: a review of 13 cases. The Clinical Journal of Pain 2005;21(4):364-9.
11. Benitez-Rosario 2004 Benitez-Rosario MA, Feria M, Salinas-Martin A, Martinez-Castillo LP, Martin-Ortega JJ. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain. Cancer 2004;101(12):2866-73.
12. Bruera 1995 Bruera E, Watanabe S, Fainsinger RL, Spachynski K, Suarez-Almazor M, Inturissi C. Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain 1995;62(2):141-6.
13. Bruera 2000 Bruera E, Rico MA, Bertolino M, Moyano JR, Allende SR, wenk R, et al.A prospective, open study of oral methadone in the treatment of cancer pain. Progress in Pain Research and Management 2000;16:957-63.
14. Daeninck 1998 Daeninck P, Watanabe S, Walker P, Bruera E. Effective pain relief in cancer patients using methadone at extended dosing intervals. Abstracts of 12th International Congress on Care of the Terminally Ill. 1998:117.
15. De Conno 1996 De Conno F, Groff L, Brunelli C, Zecca E, Ventafridda V, Ripamonti C. Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. Journal of Clinical Oncology 1996;14(10):2836-42.
16. Fisher 2004 Fisher K, Stiles C, Hagen NA. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study. Journal of Pain and Symptom Management 2004;28(6):619-25.
17. Gagnon 1999 Gagnon B, Bruera E. Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain. Journal of Pain and Symptom Management 1999;18(2):120-5.
18. Hagen 1999 Hagen NA, Wasylenko E. Methadone: outpatient titration and monitoring strategies in cancer patients. Journal of Pain and Symptom Management 1999;18(5):369-75.
19. Hansen 1982 Hansen J, Ginman C, Hartvig P, Jakobsson PA, Nilsson MI, Rane A, et al.Clinical evaluation of oral methadone in treatment of cancer pain. Acta Anaesthesiologica Scandinavica 1982;Suppl 74:124-7.
20. Hernandez Aguado '93 Hernandez Aguado C.Treatment of chronic pain with epidural methadone. UMI Digital Dissertations - Citation and Abstract 1993:228.
21. Inturrisi 1987 Inturissi CE, Colburn WA, Kaiko RF, Houde RW, Foley KM. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clinical Pharmacology and Therapeutics 1987;41(4):392-401.
22. Inturrisi 1990 Inturissi CE, Portenoy RK, Max MB, Colburn WA, Foley KM. Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clinical Pharmacology and Therapeutics 1990;47(5):565-77.
23. Kepes 1983 Kepes ER, Raj S, Thomas P, Vemulapalli K. Methadone and intravenous morphine requirements. Treatment of pain due to advanced cancer. New York State Journal of Medicine 1983;83(7):925-7.
24. Leng 1994 Leng G, Finnegan MJ. Successful use of methadone in nociceptive cancer pain unresponsive to morphine. Palliative Medicine 1994;8(2):153-5.
25. Madsen 1981 Madsen OG, Christoffersen I, Philbert A. Oral analgesic treatment for patients in the terminal stages of cancer [Peroral analgetisk behandling med metadonmikstur til cancerpatienter i terminalstadiet]. Ugeskrift for Laeger 1981;143(25):1591-5.
26. Mercadante 1996 Mercadante S, Sapio M, Serretta R, Caligara M. Patient-controlled analgesia with oral methadone in cancer pain: preliminary report. Annals of Oncology 1996;7(6):613-7.
27. Mercadante 1997 Mercadante S, Sapio M, Serretta R. Treatment of pain in chronic bowel subobstruction with self-administration of methadone. Support Care Cancer 1997;5(4):327-9.
28. Mercadante 1999a Mercadante S, Casuccio A, Agnello A, Barresi L. Methadone response in advanced cncer patients with pain followed at home. Journal of Pain and Symptom Management 1999;18(3):188-92.
29. Mercadante 1999b Mercadante S, Casuccio A, Calderone L. Rapid switching from morphine to methadone in cancer patients with poor response to morphine. Journal of Clinical Oncology 1999;17(10):3307-12.
30. Mercadante 2001 Mercadante S, Casuccio A, Fulfaro F, Groff L, Boffi R, Villari P, Gebbia V, Ripamonti C. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study. Journal of Clinical Oncology 2001;19(11):2898-904.
31. Mercadante 2005 Mercadante S, Ferrera P, Villari P, Casuccio A. Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol 2005;23(22):5229-5234.
32. Miser 1985 Miser AW, Miser JS. The use of oral methadone to control moderate and severe pain in children and young adults with malignancy. Clinical Journal of Pain 1985;1(4):243-8.
33. Morley 1993 Morley JS, Watt JWG, Wells JC, Miles JB, Finnegan MJ, Leng G. Mathadone in pain uncontrolled by morphine. Lancet 1993;342(8881):1243.
34. Morley 2002 Morley JS, Bridson J, Nash TP, Miles JB, White S, Makin MK. Low dose methadone relieves neuropathic pain in a double-blind randomised controlled crossover trial. Unpublished research (2002).
35. Paalzow 1983 Paalzow L, Loof G, Andersson B, Kullman S, Andersson B. Long-term pain relief by rectal methadone therapy [Langvarig smartlindring vid rektal metadonbehandling]. Lakartidningen 1983;80(3):114-6.
36. Ripamonti 1995 Ripamonti C, Zecca E, Brunelli C, Rizzio E, Saita L, Lodi F, et al.Rectal methadone in cancer patients with pain. A preliminary clinical and pharmacokinetic study. Annals of Oncology 1995;6(8):841-3.
37. Ripamonti 1998 Ripamonti C, Groff L, Brunelli C, Polastri D, Stavrakis A, De Conno F. Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio?. Journal of Clinical Oncology 1998;16(10):3216-21.
38. Santiago-Palma 2001 Santiago-Palma J, Khojainova N, Kornick C, Fischberg DJ, Primavera LH, Payne R, Manfredi P. Intravenous methadone in the management of chronic cancer pain. Safe and effective starting doses when substituting methadone for fentanyl. Cancer 2001;92(7):1919-25.
39. Sawe 1981 Sawe J, hansen J, Ginman C, Hartvig P, Jakobsson PA, Nilsson M-I, Rane A, Anggard E. Patient-controlled dose regimen of methadone for chronic cancer pain. BMJ 1981;282(6266):771-3.
40. Scholes 1999 Scholes CF, Gonty N, Trotman IF. Methadone titration in opioid-resistant cancer pain. European Journal of Cancer Care 1999;8(1):26-9.
41. Shir 1991 Shir Y, Shapira SS, Shenkman Z, Kaufman B, Magora F. Continuous epidural methadone treatment for cancer pain. Clinical Journal of Pain 1991;7(4):339-41.
42. Shir 1998 Shir Y, Shenkman Z, Shavelson V, Davidson EM, Rosen G. Oral methadone for the treatment of severe pain in hospitalised children: a report of five cases. Clinical Journal of Pain 1998;14(4):350-3.
43. Shir 2001 Shir Y, Rosen G, Zeldin A, Davidson EM. Methadone is safe for treating hospitalised patients with severe pain. Canadian Journal of Anesthesia 2001;48(11):1109-13.
44. Weinstein 2006 Weinstein SM, Minggao S, Buckley BJ, Kwarcinski MA. Multicentre, open-label, prospective evaluation of the conversion from previous opioid analgesics ro extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain. Clinical Therapeutics 2006;28(1):86-98.
45. Blackburn 2002 Blackburn D, Somerville E, Squire J. Methadone: an alternative conversion regime. European Journal of Palliative Care 2002;9(3):93-6.
46. Bruera 1991 Bruera E, Fainsinger R, Moore M, Thibault R, Spoldi E, Ventafridda V. Local toxcity with subcutaneous methadone. Experience of two centers. Pain 1991;45:141-3.
47. Bruera 1995a Bruera E, Schoeller T, Wenk R, MacEachern T. A prospective multicenter assessment of the Edmonton staging system for cancer pain. Journal of Pain and Symptom Management 1995;10(5):348-55.
48. Bruera 2002 Bruera E, Sweeney C. Methadone use in cancer patients with pain: a review. Journal of Palliative Medicine 2002;5(1):127- 38.
49. Davis 2001 Davis MP, Walsh D. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer 2001;9:73-83.
50. Fainsinger 1993 Fainsinger R, Schoeller T, Bruera E. Methadone in the management of cancer pain: a review. Pain 1993;51:137-47.
51. Foley 1998 Foley KM. Pain assessment and cancer pain syndromes. In: DoyleD, HanksGWC, MacDonaldN editor(s). Oxford textbook of palliative medicine. Oxford: Oxford University Press, 1998:310-31.
52. Gannon 1997 Gannon C. The use of methadone in the care of the dying. European Journal of Palliative Care 1997;4(5):152-8.
53. Hanks 1998 Hanks GWC, Cherny N. Opioid analgesic therapy. In: DoyleD, HanksGWC, MacDonaldN editor(s). Oxford textbook of palliative medicine. Oxford: Oxford University Press, 1998:331-51.
54. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
55. Jadad 1998 Jadad AR. Randomised controlled trials. London: BMJ Books, 1998.
56. Klepstad 2006 Klepstad P. Opioid analgesia: new insights. European Journal of Palliative Care 2006;13(5):185-7.
57. Martindale 1999 Parfitt K. Martindale: The complete drug reference. 2nd Edition. London: Pharmaceutical Press, 1999.
58. Mathew 1999 Mathew P, Storey P. Subcutaneous methadone in terminally ill patients: manageable local toxicity. Journal of Pain and Symptom Management 1999;18(1):49-52.
59. Morley 1998 Morley JS, Makin MK. The use of methadone in cancer pain poorly responsive to other opioids. Pain Reviews 1998;5:51-8.
60. Payne 1998 Payne R, Gonzales GR. Pathophysiology of pain in cancer and other terminal diseases. In: DoyleD, HanksGWC, MacDonaldN editor (s). Oxford textbook of palliative medicine. Oxford: Oxford University Press, 1998:299-310.
61. Ripamonti 1997 Ripamonti C, Zecca E, Bruera E. An update on the clinical use of methadone for cancer pain. Pain 1997;70:109-15.
62. Twycross 1998 Twycross R, Wilcock A, Thorpe S. Palliative Care Formulary. Oxford: Radcliffe Medical Press, 1998.